APLS
Price
$68.47
Change
+$0.88 (+1.30%)
Updated
Feb 23, 6:59 PM EST
2 days until earnings call
ASND
Price
$159.40
Change
+$1.20 (+0.76%)
Updated
Feb 23, 6:59 PM EST
87 days until earnings call
Ad is loading...

Analysis and predictions APLS vs ASND

Header iconAPLS vs ASND Comparison
Open Charts APLS vs ASNDBanner chart's image
Apellis Pharmaceuticals
Price$68.47
Change+$0.88 (+1.30%)
Volume$388.2K
CapitalizationN/A
Ascendis Pharma A/S
Price$159.40
Change+$1.20 (+0.76%)
Volume$136.15K
CapitalizationN/A
View a ticker or compare two or three
APLS vs ASND Comparison Chart

Loading...

APLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ASNDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
APLS vs. ASND commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Buy and ASND is a Hold.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (APLS: $68.47 vs. ASND: $159.40)
Brand notoriety: APLS and ASND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 47% vs. ASND: 59%
Market capitalization -- APLS: $8.11B vs. ASND: $9.02B
APLS [@Biotechnology] is valued at $8.11B. ASND’s [@Biotechnology] market capitalization is $9.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileASND’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • ASND’s FA Score: 0 green, 5 red.
According to our system of comparison, both APLS and ASND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while ASND’s TA Score has 4 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 3 bearish.
  • ASND’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, APLS is a better buy in the short-term than ASND.

Price Growth

APLS (@Biotechnology) experienced а -0.45% price change this week, while ASND (@Biotechnology) price change was +1.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

APLS is expected to report earnings on May 02, 2024.

ASND is expected to report earnings on May 22, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for APLS with price predictions.
OPEN
A.I.dvisor published
a Summary for ASND with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ASND($9.02B) has a higher market cap than APLS($8.11B). ASND YTD gains are higher at: 26.558 vs. APLS (14.384). ASND has higher annual earnings (EBITDA): -411.17M vs. APLS (-575.25M). APLS has more cash in the bank: 452M vs. ASND (399M). APLS has less debt than ASND: APLS (110M) vs ASND (644M). APLS (273M) and ASND (267M) have equivalent revenues.
APLSASNDAPLS / ASND
Capitalization8.11B9.02B90%
EBITDA-575.25M-411.17M140%
Gain YTD14.38426.55854%
P/E RatioN/AN/A-
Revenue273M267M102%
Total Cash452M399M113%
Total Debt110M644M17%
FUNDAMENTALS RATINGS
APLS vs ASND: Fundamental Ratings
APLS
ASND
OUTLOOK RATING
1..100
3550
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
3737
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
2950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APLS's Valuation (83) in the Medical Distributors industry is in the same range as ASND (89) in the Biotechnology industry. This means that APLS’s stock grew similarly to ASND’s over the last 12 months.

APLS's Profit vs Risk Rating (37) in the Medical Distributors industry is in the same range as ASND (37) in the Biotechnology industry. This means that APLS’s stock grew similarly to ASND’s over the last 12 months.

APLS's SMR Rating (99) in the Medical Distributors industry is in the same range as ASND (100) in the Biotechnology industry. This means that APLS’s stock grew similarly to ASND’s over the last 12 months.

ASND's Price Growth Rating (36) in the Biotechnology industry is in the same range as APLS (38) in the Medical Distributors industry. This means that ASND’s stock grew similarly to APLS’s over the last 12 months.

ASND's P/E Growth Rating (100) in the Biotechnology industry is in the same range as APLS (100) in the Medical Distributors industry. This means that ASND’s stock grew similarly to APLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLSASND
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 18 days ago
77%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
APLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ASNDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VMBS45.280.21
+0.47%
Vanguard Mortgage-Backed Secs ETF
ONEY101.280.33
+0.33%
SPDR® Russell 1000® Yield Focus ETF
DYLD22.500.03
+0.15%
LeaderShares® Dynamic Yield ETF
OBIL49.95N/A
N/A
US Treasury 12 Month Bill ETF
SPCX23.17-0.04
-0.18%
SPAC and New Issue ETF

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with QNRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then QNRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+1.30%
QNRX - APLS
48%
Loosely correlated
-2.27%
MDGL - APLS
44%
Loosely correlated
-4.82%
KRYS - APLS
42%
Loosely correlated
-0.56%
AXON - APLS
33%
Loosely correlated
-0.34%
ASND - APLS
33%
Loosely correlated
+0.76%
More

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
+0.76%
MDGL - ASND
41%
Loosely correlated
-4.82%
MGTX - ASND
40%
Loosely correlated
+0.35%
CYTK - ASND
39%
Loosely correlated
+3.21%
ORMP - ASND
37%
Loosely correlated
+4.85%
RVNC - ASND
36%
Loosely correlated
+3.39%
More